Navigation Links
Ganeden Biotech and Heartland Sweeteners to Produce Probiotic Sweetener

Leaders in probiotics and artificial sweeteners partner to produce world's first probiotic-enhanced sweetener; collaboration promises to bring innovation to baking aisle

INDIANAPOLIS, March 3 /PRNewswire/ -- Ganeden Biotech, Inc. a Cleveland-based manufacturer of the patented probiotic strain GanedenBC30, today announced an exclusive partnership with Heartland Sweeteners, an Indianapolis-based leading innovator of health and wellness products and calorie-free sweeteners, to produce a new probiotic-enhanced sweetener.

The companies will work together in the coming months to develop a no-calorie artificial sweetener to be distributed nationally in retail grocers, including many already carrying Heartland Sweeteners' Nevella(R) line. The new sweetener can be used in a variety of traditional sweetener applications, as well as in baked goods as a healthy, no-calorie alternative.

"This collaboration marks a significant step forward in our effort to take probiotics beyond the yogurt aisle," said Andrew Lefkowitz, CEO of Ganeden Biotech. "We are partnering with Heartland Sweeteners to quickly bring to market an innovative product that can help support and maintain a healthy digestive system and boost immunity."

Heartland Sweeteners chose Ganeden Biotech's patented probiotic bacteria, GanedenBC30, because of its unique ability to survive manufacturing and baking temperatures and remain shelf stable. GanedenBC30's superior survivability can be attributed to its protection by an organic shell, which allows the bacteria to reach the digestive tract alive and in large numbers where it can provide the greatest benefits to consumers.

"By partnering with Ganeden Biotech, we can produce a sweetener that not only helps foods and beverages taste great, but also provides health benefits," said Michael Servie, President of Heartland Sweeteners. "Consumers now have an alternative to yogurts and dairy drinks and can now strengthen their body's defenses simply by adding this new product to their coffee, tea and baked goods."

The collaboration is the latest partnership between Ganeden Biotech and national manufacturers looking to bring digestive and immune health benefits to new product offerings. "In recent months Ganeden Biotech has partnered with several companies to expand probiotics products beyond the refrigerated section of the grocery store."

About Ganeden Biotech

Founded in 1997, Ganeden Biotech, Inc. is based in Cleveland, Ohio and is the largest seller of over-the-counter probiotics in the U.S. through its Digestive Advantage(R) and Sustenex(TM) brands. It also licenses its patented probiotic bacteria, GanedenBC30, for use in commercial food and beverage applications, medical foods, nutraceuticals and in animal health industries. GanedenBC30 is self-affirmed GRAS (Generally Recognized As Safe) by an independent panel of experts assembled to assess its safety in use as a food ingredient. For more information about licensing, visit For probiotic supplement information, visit or

About Heartland Sweeteners

Based in Indianapolis, Heartland Sweeteners, LLC., is a leader in the production and development of innovative food products that are great for the whole family. Heartland produces and distributes branded and private label sweeteners for the food industry. Their branded products of Nevella(R) and ideal(TM) are great for the whole family, diabetics and people watching their calorie intake. Both Nevella and ideal are great for baking and are distributed throughout North America and expanding into Europe, Central and South America. Visit Heartland at and

    Russ Rizzo, Linhart PR

SOURCE Ganeden Biotech Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Ganeden Biotech Receives Frost & Sullivan Probiotics Product Innovation Award
2. Isabellas Healthy Bakery Unveils Activate - A New Probiotic Muffin Fortified with GanedenBC30 Probiotic
3. Ganeden Biotech Takes Sustenex(TM) National with GanedenBC30 Probiotic
4. Ganeden Biotech Obtains Self-Affirmed GRAS Status for Probiotic Ingredient, GanedenBC30 (Bacillus coagulans GBI-30, 6086)
5. Morningstar Healthcare Analysts to Discuss Top 15 Biotech Acquisition Targets on Wednesday, March 4 at 11 a.m. EST
6. PDS Biotechnology Corporation Finalizes Commercial Licensing Agreement with Merck Eprova AG to Utilize Merck Eprovas Enantiomers of DOTAP Chloride in Immunotherapies
7. Investor Group Files Complaint With Irish Office of the Director of Corporate Enforcement Against Named Directors of Trinity Biotech
8. Axial Biotech Appoints Dr. Roberto Macina to Vice President of Research and Development
9. DuPont Biotech Stewardship Program Gains External Certification
10. Yongye Biotechnology Announces Preliminary Results for Fiscal Year 2008
11. Hong Kong Biotech Company, Filligent, Announces CE Certification of Its Revolutionary, Anti-Infective Medical Face Mask, the BioMask
Post Your Comments:
(Date:11/23/2015)... VA (PRWEB) , ... November 23, 2015 , ... Noblis, ... McCarthy , former Director, Plans and Programs, National Geospatial Intelligence Agency (NGA), has joined ... us with an incredibly distinguished career in the intelligence community and the private sector,” ...
(Date:11/23/2015)... , November 23, 2015 biochar ... million in 2015, and it is expected to grow ... The factors driving the growth of the global market ... sequestration property of biochar, increased government initiatives and stringent ... initiatives and stringent environment regulations are the key drivers ...
(Date:11/23/2015)... Fla. , Nov. 23, 2015  Oxis ... Oxis International, Inc. [OTC: OXIS] and [Euronext Paris: ... of Minnesota Masonic Cancer Center received notification from ... they can proceed with their planned combination Phase ... worldwide exclusive rights to develop and commercialize OXS-1550, ...
(Date:11/23/2015)... 2015 ) ... Global Molecular Diagnostics Market: Latest Instrumentation and ... to their offering.  --> ... "2016 Global Molecular Diagnostics Market: Latest Instrumentation ...  report to their offering.  --> ...
Breaking Biology Technology:
(Date:11/2/2015)... PARK, Calif. , Nov. 2, 2015  SRI ... $9 million to provide preclinical development services to the ... the contract, SRI will provide scientific expertise, modern testing ... wide variety of preclinical pharmacology and toxicology studies to ... --> The PREVENT Cancer Drug Development ...
(Date:10/29/2015)... ANN ARBOR, Mich. , Oct. 29, 2015 ... with Eurofins Genomics for U.S. distribution of its ... DNA-seq kit and Rubicon,s new ThruPLEX Plasma-seq ... DNA to enable the preparation of NGS libraries ... in plasma for diagnostic and prognostic applications in ...
(Date:10/27/2015)... , Oct. 27, 2015 In the ... issues of concern for various industry verticals such as ... due to the growing demand for secure & simplified ... various ,sectors, such as hacking of bank accounts, misuse ... electronic equipment such as PC,s, laptops, and smartphones are ...
Breaking Biology News(10 mins):